COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,629 Articles (22,913 medRxiv, 8,716 bioRxiv)

Most recent first Previous |  Page 645: Articles 6441-6450  | Next

SARS-CoV-2 seroprevalence and implications for population immunity: Evidence from two Health and Demographic Surveillance System sites in Kenya, February-June 2022
Kagucia, E. W., Ziraba, A. K., Nyagwange, J., Kutima, B., Kimani, M., Akech, D., Ng'oda, M., Sigilai, A., Mugo, D., Karanja, H., Karani, A., Toroitich, M., Karia, B., Otiende, M., Njeri, A., Aman, R. A., Amoth, P., Mwangangi, M., Kasera, K., Ng'ang'a, W., Voller, S., Ochola-Oyier, L. I., Bottomley, C., Nyaguara, A., Munywoki, P. K., Bigogo, G., Maitha, E., Uyoga, S., Gallagher, K. E., Etyang, A. O., Barasa, E., Mwangangi, J., Bejon, P., Adetifa, I. M. O., Warimwe, G. M., Scott, J. A., Agweyu, A.
10.1101/2022.10.10.22280824 — Posted: 2022-10-11
Assessing the epidemic impact of protests during the COVID-19 pandemic
Hong, I., Ferreira, L. N., Rutherford, A., Cebrian, M.
10.1101/2022.10.10.22280896 — Posted: 2022-10-11
Bridging machine learning and compartment models to predict an epidemic
Chau, M. T.
10.1101/2022.10.07.22280853 — Posted: 2022-10-11
Innate immune sensing of self-derived double-stranded RNA by RIG-I-MAVS-TNF-α regulates the survival and senescence fate of SARS-2-S syncytia
Wan, L., Li, H., Huang, L., Liu, M., Li, J., Yang, Y., Zhao, R., Liu, J., Yang, X., Ma, E., Sun, L., Hou, X., Zhang, X., Zhang, Y., Yan, Q., Liu, J., Li, X., Cheng, G., Gao, Q., Xu, J., Hou, L., Wei, C., Zhong, H.
10.1101/2022.10.10.511541 — Posted: 2022-10-11
MIGH-T: A Multi-Parametric and High-Throughput Platform for Host-Virus Binding Screens
Schlegel, J., Porebski, B., Andronico, L., Hanke, L., Edwards, S., Brismar, H., Murrell, B., McInerney, G. M., Fernandez-Capetillo, O., Sezgin, E.
10.1101/2022.10.10.511545 — Posted: 2022-10-11
Comparative efficacy of antiviral strategies targeting different stages of the viral life cycle: A viral quasispecies dynamics study
Lwin, P., Das, M., Jones, B. A.
10.1101/2022.10.10.511620 — Posted: 2022-10-11
Genomic tracking of SARS-COV-2 variants in Myanmar
Oo, K. Z., Htun, Z. W., Aung, N. M., Win, K. K., Htoo, S. P., Oo, T. W., Linn, K. Z., Aung, P. K., Zaw, M. T., Tun, K. M., Myint, K., Lwin, K. K.
10.1101/2022.10.10.511623 — Posted: 2022-10-11
GenSLMs: Genome-scale language models reveal SARS-CoV-2 evolutionary dynamics.
Zvyagin, M. T., Brace, A., Hippe, K., Deng, Y., Zhang, B., Orozco Bohorquez, C., Clyde, A., Kale, B., Perez-Rivera, D., Ma, H., Mann, C. M., Irvin, M., Pauloski, J. G., Ward, L., Hayot, V., Emani, M., Foreman, S., Xie, Z., Lin, D., Shukla, M., Nie, W., Romero, J., Dallago, C., Vahdat, A., Xiao, C., Gibbs, T., Foster, I., Davis, J. J., Papka, M. E., Brettin, T., Anandkumar, A., Vishwanath, V., Ramanathan, A.
10.1101/2022.10.10.511571 — Posted: 2022-10-11
Psychophysiologic symptom relief therapy (PSRT) for post-acute sequelae of COVID-19: a non-randomized interventional study
Donnino, M. W., Howard, P., Mehta, S., Silverman, J., Cabrera, M. J., Yamin, J. B., Balaji, L., Tolin, R., Berg, K. M., Edwards, R., Grossestreuer, A. V.
10.1101/2022.10.07.22280732 — Posted: 2022-10-10
Gut microbial disruption in critically ill patients with COVID-19 associated pulmonary aspergillosis
Schult, D., Maurer, C., Koyumdzhieva, P., Reitmeier, S., Middelhoff, M., Rasch, S., List, M., Janssen, K.-P., Steiger, K., Protzer, U., Schmid, R. M., Neuhaus, K., Haller, D., Quante, M., Lahmer, T.
10.1101/2022.10.08.511408 — Posted: 2022-10-10

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).